Medifast earnings were -$20.0M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest MED earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$2.1M, down 88.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, MED reported annual earnings of -$18.7M, with -993% growth. The next MED earnings date is Aug 3, 2026.
On MED's earnings call on May 4, 2026, Medifast (NYSE: MED) reported Q1 2026 earnings per share (EPS) of -$0.19, up 171.43% year over year. Total MED earnings for the quarter were -$2.12 million. In the same quarter last year, Medifast's earnings per share (EPS) was -$0.07.
The next MED earnings call is Aug 3, 2026. Add MED to your watchlist to be reminded of Medifast's next earnings date.
Is Medifast profitable or losing money?
As of the last Medifast earnings report, Medifast is currently losing money. Medifast's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$20.02 million, a 186.19% increase year over year.
What was MED's earnings growth in the past year?
As of Medifast's earnings date in May 4, 2026, Medifast's earnings has grown year over year. MED earnings in the past year totalled -$20.02 million.
What are Medifast's earnings expectations?
The current EPS estimate for Medifast's earnings report in Aug 3, 2026 is -$0.68.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.